Ray Therapeutics received EMA PRIME designation for its RTx-015 optogenetic gene therapy for retinitis pigmentosa, following recent FDA RMAT status. The company also appointed Michael Murtagh as Chief Regulatory Officer to support global development.
Relay Therapeutics reported full-year 2025 revenue of $15.36 million and a narrowed net loss of $276.48 million, while securing FDA Breakthrough Therapy designation for lead asset zovegalisib. The company filed a $96.18 million shelf registration.
The global biotechnology market is undergoing a transformation from discovery-based science to precision engineering, driven by AI, synthetic biology, and gene editing technologies, with projected growth of 13-15% over the next five years.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07365254 |
Accurate Assessment and Intervention Research on Newborn Whole Genome Sequencing and Genetic Disease Risk |
RECRUITING | |
| NCT07222371 |
An Open-label, Single Center, Single Participant Study of an Experimental Antisense Oligonucleotide Treatment for TUBB4A-related Leukodystrophy |
ACTIVE_NOT_RECRUITING | PHASE1/PHASE2 |
| NCT07119606 |
Multicenter Study of Patients With SHANK3 Mutations: Identification of Genes Modificators in Phelan-McDermid Syndrome (EUQ13) |
NOT_YET_RECRUITING | NA |
| NCT07106853 |
Prenatal Cell-free DNA Screening in Pregnancies With Diverse Genetic Risk Profiles Utilizing Targeted and Whole-exome Sequencing |
NOT_YET_RECRUITING | |
| NCT07040774 |
Natural History of Type 1 Interferonopathies: Insights From a European Cohort |
RECRUITING | |
| NCT07039084 |
Using a Speech-Generating Device to Support Communication in Childhood Dementia |
RECRUITING | NA |
| NCT06981520 |
Caspase-1 Activity, IL-1beta, and IL-18 in Patients With FMF |
NOT_YET_RECRUITING | |
| NCT06935253 |
Large Language Models To Improve the Quality of Care of Cardiology Patients |
RECRUITING | NA |
| NCT06926127 |
Genomic Profiling of Genetic and Rare Diseases |
RECRUITING | NA |
| NCT06898307 |
Utility of Gene Test Analysis for Diagnosis, Prognosis and Treatment of Patients With Genetic Arrhythmic Heart Disease: the ARRHYTHMIC GENE-HEART |
RECRUITING |
